Byetta (exenatide): what's your gut feeling?
Hutton
Sarah F
SF
Department of Clinical Pharmacy, South Dakota State University, USA.
D017326:Clinical Trials, Phase III as Topic; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D000077270:Exenatide; D052216:Glucagon-Like Peptide 1 / Q000819:agonists*; D006801:Humans; D010455:Peptides / Q000494:pharmacology*; D014688:Venoms / Q000494:pharmacology*
D010455:Peptides; D014688:Venoms; D052216:Glucagon-Like Peptide 1; D000077270:Exenatide